JEUDIS DE LA FACULTE - Frontiers in Biomedicine, Prof. Michael PLATTEN
26.01.2017 12:30 – 13:30
«Targeting driver mutations in gliomas using immunotherapy - from bench to bedside and back»
With the successes of checkpoint inhibitors and engineered T cells cancer immunotherapy has made major progress in recent years. Personalization and tumoral heterogeneity have remained major challenges in the field. This presentations highlights the potential of targeting driver mutations in cancer to circumvent these challenges exemplified by preclinical and clinical studies targeting driver mutations in gliomas.
«A pioneer in the field of brain tumor immunology, sailing between auto-immunity and tumor immunity, moving from neurology to neuro-oncology, always with the same high level of perception and lucidity.»
Prof. Pierre-Yves DIETRICH, Host
Département de médecine interne des spécialités, Faculté de Médecine, UNIGE
Médecin-chef du Service d'oncologie, HUG
Lieu
Bâtiment: CMU
Auditoire C150
Organisé par
Faculté de médecineIntervenant-e-s
Prof. Dr. med. Michael PLATTEN, Chairman, Department of Neurology University Hospital Mannheim, Heidelberg University - Head, Clinical Cooperation Unit, Neuroimmunology and Brain Tumor Immunology, German Cancer Research Centerentrée libre
Classement
Catégorie: Séminaire
Mots clés: Frontiers in Biomedicine, Recherche, séminaire, conférence, Oncologie, Immunologie, tumeur cérébrale
Fichiers joints
afficheA3_FIB_Platten.pdf | 153.1 Kb |